Journal article
New molecular medicine-based scar management strategies
Abstract
Keloids and hypertrophic scars are prevalent disabling conditions with still suboptimal treatments. Basic science and molecular-based medicine research have contributed to unravel new bench-to-bedside scar therapies and to dissect the complex signalling pathways involved. Peptides such as the transforming growth factor beta (TGF-β) superfamily, with Smads, Ski, SnoN, Fussels, endoglin, DS-Sily, Cav-1p, AZX100, thymosin-β4 and other related …
Authors
Arno AI; Gauglitz GG; Barret JP; Jeschke MG
Journal
Burns, Vol. 40, No. 4, pp. 539–551
Publisher
Elsevier
Publication Date
June 2014
DOI
10.1016/j.burns.2013.11.010
ISSN
0305-4179